Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

Travis K. Warren(United States Army Medical Research Institute of Infectious Diseases), Jay Wells(United States Army Medical Research Institute of Infectious Diseases), Rekha G. Panchal(United States Army Medical Research Institute of Infectious Diseases), Kelly S. Stuthman(United States Army Medical Research Institute of Infectious Diseases), Nicole L. Garza(United States Army Medical Research Institute of Infectious Diseases), Sean A. Van Tongeren(United States Army Medical Research Institute of Infectious Diseases), Lián Dŏng(United States Army Medical Research Institute of Infectious Diseases), Cary Retterer(United States Army Medical Research Institute of Infectious Diseases), Brett Eaton(United States Army Medical Research Institute of Infectious Diseases), Gianluca Pegoraro(United States Army Medical Research Institute of Infectious Diseases), Shelley P. Honnold(United States Army Medical Research Institute of Infectious Diseases), Shanta Bantia(BioCryst Pharmaceuticals (United States)), Pravin L. Kotian(BioCryst Pharmaceuticals (United States)), Xilin Chen(BioCryst Pharmaceuticals (United States)), Brian R. Taubenheim(BioCryst Pharmaceuticals (United States)), Lisa S. Welch(United States Army Medical Research Institute of Infectious Diseases), Dena M. Minning(3-Sigma Research (United States)), Y.S. Babu(BioCryst Pharmaceuticals (United States)), William Sheridan(BioCryst Pharmaceuticals (United States)), Sina Bavari(United States Army Medical Research Institute of Infectious Diseases)
Nature
March 2, 2014
Cited by 604Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis